Skip to content

Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance

Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance, Inflammation, Gene Expression and Epigenetic Signatures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03259412
Acronym
FAT
Enrollment
18
Registered
2017-08-23
Start date
2016-01-01
Completion date
2017-12-20
Last updated
2018-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise-induced Inflammation

Brief summary

The aim of the study is to determine whether fish oil (specifically omega-3 long chain polyunsaturated fatty acids \[EPA-DHA\]) supplementation can enhance eccentric resistance exercise performance when combined with a resistance exercise training study. The investigators aim to establish the potential mechanisms that might mediate performance changes at a cellular level.

Interventions

DIETARY_SUPPLEMENTFish Oil

Fish Oil Capsule

DIETARY_SUPPLEMENTPlacebo

Olive Oil capsule manufactured to mimic fish oil capsule

Sponsors

Loughborough University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Males * Healthy

Exclusion criteria

* Resistance exercise training within the past 6 months * Vitamin or fish oil supplementation over the past 6 months * Habitual use of anti-inflammatory drugs * History of heart disease * History of coagulation/bleeding disorder * History of metabolic disease * Serious allergy * Known to have blood-borne virus * Females (Due to differences in cell membrane incorporation of Omega-3 between the sexes and the testing schedule being unable to fit in with menstrual cycle, altering the blood markers that are being measured) * Currently no symptoms of general illness

Design outcomes

Primary

MeasureTime frameDescription
StrengthChange from baseline strength at 11 weeksQuadriceps and Hamstring strength using an isokinetic dynamometer
Leg powerChange from baseline strength at 11 weeksDynamic leg power assessed through jump height on force platform

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026